肝性脑病的新认识-从指南到临床

doi:10.3969/j.issn.1672-5069.2016.01.005

Abstract

Chen Dongfeng, Sun Wenjing. New concept of hepatic encephalopathy:from guideline to clinical practice[J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2016, 19(1): 16-19.

[1] Blei AT,Cordoba J. Parameters Committee of the American College of Gastroenterology. Hepatic encephalopathy. Am J Gastroenterol,2001,96（7）:1986-1976.
[2] Ferenci P,Lockwood A,Mullen K,et al. Hepatic encephalopathy-definition,nomenclature,diagnosis,and quantificiation:final report of the working party at the 11th World Congresses of Gastroenterology,Vienna,1998. Hepatology,2002,35（3）:716-721.
[3] Dhiman RK,Saraswat VA,Sharma BK,et al. Minimal hepatic encephalopathy:consensus statement of a working party of the Indian National Association for Study of the Liver. J Gastroenterol Hepatol,2010,25（6）:1029-1041.
[4] Wang JY,Zhang NP,Chi BR,et al. Prevalence of minimal hepatic encephalopathy and quality of life evaluations in hospitalized cirrhotic patients in China. World J Gastroenterol,2013,19（30）:4984-4991.
[5] 中华医学会消化病学分会,中华医学会肝病学分会. 中国肝性脑病诊治共识意见（2013年,重庆）. 中华肝脏病杂志,2013,21（9）:641-651.
[6] Vilstrup H,Amodio P,Bajaj J,et al. Hepatic encephalopathy in chronic liver disease:2014 practice guideline by the American Association for the study of liver diseases and the European association for the study of the liver. Hepatology,2014,60（2）: 715-735.
[7] Gronbaek H,Johnsen SP,Jepsen P,et al. Liver cirrhosis,other liver diseases,and risk of hospitalization for intracerebral haemorrhage:a Danish population-based case-control study. BMC Gastroenterol,2008,8:16-21.
[8] Waghray A,Waghray N,Mullen K. Management of covert hepatic encephalopathy. J Clin Exp Hepatol,2015,5（S1）: S75-S81.
[9] Weissenborn K. Diagnosis of minimal hepatic encephalopathy. J Clin Exp Hepatol,2015,5（S1）:S54-S59.
[10] Dhiman RK,Kurmi R,Thumburu KK,et al. Diagnosis and prognostic significance of minimal hepatic encephalopathy in patients with cirrhosis of liver. Dig Dis Sci,2010,55:2381-2390.
[11] Riggio O,Ridola L,Pasquale C,et al. A simplified psychometric evaluation for the diagnosis of minimal hepatic encephalopathy. Clin Gastroenterol Hepatol,2011,9（7）:613-616.
[12] Das S,Ali S M,Seward J,et al. The mind and liver test:a new approach to the diagnosis of minimal hepatic encephalopathy in resource-poor settings. Int J Hepatol,2014,2014:475021.
[13] Romero-Gomez M,Cordoba J,Jover R,et al. Value of the critical flicker frequency in patients with minimal hepatic encephalopathy. Hepatology,2007,45（4）:879-885.
[14] Wu D,Wu S M,Lu J,et al. Rifaximin versus nonabsobable disaccharides for the treatment of hepatic encephalopathy:a meta-analysis. Gastroenterol Res Pract,2013,2013:236963.
[15] Jiang Q,Jiang X H,Zheng M H,et al. Rifaximin versus nonabsobale disaccharides in the management of hepatic encephalopathy:a meta-analysis. Eur J Gastroenterol Hepatol,2008,20（11）:1064-1070.
[16] Scott LJ. Rifaximin: a review of its use in reducing recurrence of overt hepatic encephalopathy episodes. Drugs,2014,74（18）: 21532-2160.
[17] Khokhar N,Qureshi MO,Ahmad S,et al. Comparison of once a day rifaximin to twice a day dosage in prevention of recurrence of hepatic encephalopathyin patients with chronic liver disease. J Gastroenterol Hepatol,2015,Apr 13. doi:10.1111/jgh.12970. [Epub ahead of print].
[18] Zhu GQ,Shi KQ,Huang S,et al. Systematic review with network meta-analysis:the comparative effectiveness and safety of interventions in patients with overt hepatic encephalopathy. Aliment Phamacol Ther,2015,41（7）:624-635.

New concept of hepatic encephalopathy:from guideline to clinical practice

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics

Comments

[1]	Bao Yingjun, Ren Weixin.. Interventional therapy for patients with portal vein thrombosis [J]. Journal of Practical Hepatology, 2019, 22(6): 768-769.
[2]	National Workshop on Fatty Liver, Alcoholic Liver Disease, Chinese Society of Hepatology; National Workshop on Liver, Metabolism, Chinese Society of Endocrinology, Chinese Medical Association. Committee of Hepatology, Chinese Research Hospital Association; Fatty Liver Expert Committee, Chinese Medical Doctor Association [J]. Journal of Practical Hepatology, 2019, 22(6): 787-792.
[3]	. Consensus on the diagnosis and therapy of hepatic fibrosis [J]. Journal of Practical Hepatology, 2019, 22(6): 793-803.
[4]	Shi Yingying, Wang Yuanxi.. Impact of combination telbivudine and adefovir dipivoxil on renal functions in the treatment of patients with chronic hepatitis B [J]. Journal of Practical Hepatology, 2019, 22(6): 820-823.
[5]	Xing Xin, Wei Zhongcao, Zhou mimi, et al.. Efficacy and safety of tauroursodeoxycholic acid and ursodeoxycholic acid combination in the treatment of patients with nonalcoholic fatty liver disease:a Meta-analysis [J]. Journal of Practical Hepatology, 2019, 22(6): 852-855.
[6]	Duan Chuyao, Chen Qingshan, Wang Liming, et al.. Clinical efficacy of ursodeoxycholic acid in treatment of patients with intrahepatic cholestasis of pregnancy [J]. Journal of Practical Hepatology, 2019, 22(6): 864-867.
[7]	Chen Meimei, Duan Xiaoyan, Cao Haixia, et al.. Improvement of clinical symptoms and serum hepatic fibrosis markers in patients with primary biliary cirrhosis by compound Biejiaruangan tablets [J]. Journal of Practical Hepatology, 2019, 22(6): 880-883.
[8]	Ma Yaqiong, Li Zhilan, Xia Bing.. Early administration of enteral nutrition and microecological agents in patients with hepatic encephalopathy [J]. Journal of Practical Hepatology, 2019, 22(6): 892-895.
[9]	Cao Ce, Yu Yixing, Wang Beibei, et al.. Clinical diagnostic efficacy of enhanced magnetic resonance imaging combined with serum AFP and PIVKA-Ⅱ in the diagnosis of patients with hepatocellular carcinoma [J]. Journal of Practical Hepatology, 2019, 22(6): 896-899.
[10]	Zeng Yanni, Zhang Can, Bi Junying, et al.. Value of long-time delayed enhancement scan of MRI in the diagnosis of solitary necrotic nodule of liver [J]. Journal of Practical Hepatology, 2019, 22(6): 900-903.
[11]	Feng Wenguang, Jiang Wei, Song Guojun.. PPV-guided fluid therapy in patients with hepatolithiasis underwent partial hepatectomy [J]. Journal of Practical Hepatology, 2019, 22(6): 912-915.
[12]	Li Qiuxi, Jia Jianfeng, Huang Rui.. Clinical value of segmental pedicle hepatectomy and B-ultrasound-guided hepatectomy in the treatment of patients with hepatolithiasis [J]. Journal of Practical Hepatology, 2019, 22(6): 916-919.
[13]	Li Chuanjie, Xu Jing, Wang Liangliang, et al.. Changes of serum HBsAg levels in patients with chronic hepatitis B receiving entecavir treatment [J]. Journal of Practical Hepatology, 2019, 22(6): 928-929.
[14]	Xing Hao, Han Jun, Yang Tian.. Diagnostic value of serum protein induced by vitamin K absence or antagonist II for hepatocellular carcinoma [J]. Journal of Practical Hepatology, 2019, 22(6): 934-937.
[15]	Liang Jubo, Miao Qi, Ma Xiong.. Diagnosis and treatment of cholangiocytic cholestasis [J]. Journal of Practical Hepatology, 2019, 22(6): 941-943.